Source link : https://www.newshealth.biz/health-news/can-early-biologics-prevent-difficult-to-treat-ra/
TOPLINE: Early escalation to biologic therapies after failure of treat-to-target with methotrexate in patients with rheumatoid arthritis (RA) does not significantly reduce the risk for the development of difficult-to-treat RA. METHODOLOGY: Researchers conducted a retrospective analysis including 722 patients with new-onset RA (mean age, 60 years; 72% women) who were identified from a cohort at […]
Author : News Health
Publish date : 2024-11-20 08:38:21
Copyright for syndicated content belongs to the linked Source.
inHealth